Skip to content
10-Q

Quarterly Report

LB Pharmaceuticals Inc LBRX

0001193125-25-268174

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 25.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 5.81M sh
Shares Diluted Q3 2025 · Sep 30, 2025 2.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 359.08K sh
Shares Diluted Q3 2025 · Sep 30, 2024 357.89K sh
Capex Q3 2025 · Sep 30, 2025 $12K
Capex Q3 2025 · Sep 30, 2024 $531K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$17.11M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$47.39M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $269.74M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $22.98M
Stockholders Equity Q3 2025 · Sep 30, 2025 $310.22M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$103.87M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$99.34M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$94.55M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$91.45M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$77.44M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$50.45M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$34.47M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.65M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.11M
Total Liabilities Q3 2025 · Sep 30, 2025 $10.53M
Total Liabilities Q3 2025 · Dec 31, 2024 $13.83M
Current Assets Q3 2025 · Sep 30, 2025 $316.4M
Current Assets Q3 2025 · Dec 31, 2024 $28.88M
Total Assets Q3 2025 · Sep 30, 2025 $320.75M
Total Assets Q3 2025 · Dec 31, 2024 $33.53M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.61
Eps Diluted Q3 2025 · Sep 30, 2025 −$6.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$39.49
Eps Diluted Q3 2025 · Sep 30, 2024 −$162.15
Eps Basic Q3 2025 · Sep 30, 2025 −$0.61
Eps Basic Q3 2025 · Sep 30, 2025 −$6.26
Eps Basic Q3 2025 · Sep 30, 2024 −$39.49
Eps Basic Q3 2025 · Sep 30, 2024 −$162.15
Sga Expense Q3 2025 · Sep 30, 2025 $2.83M
Sga Expense Q3 2025 · Sep 30, 2025 $8.27M
Sga Expense Q3 2025 · Sep 30, 2024 $5.42M
Sga Expense Q3 2025 · Sep 30, 2024 $8.5M
Rd Expense Q3 2025 · Sep 30, 2025 $2.42M
Rd Expense Q3 2025 · Sep 30, 2025 $8.26M
Rd Expense Q3 2025 · Sep 30, 2024 $10.66M
Rd Expense Q3 2025 · Sep 30, 2024 $50.8M
Net Income Q3 2025 · Sep 30, 2025 −$3.56M
Net Income Q3 2025 · Sep 30, 2025 −$13.73M
Net Income Q3 2025 · Jun 30, 2025 −$4.87M
Net Income Q3 2025 · Mar 31, 2025 −$5.31M
Net Income Q3 2025 · Sep 30, 2024 −$14.18M
Net Income Q3 2025 · Sep 30, 2024 −$58.03M
Net Income Q3 2025 · Jun 30, 2024 −$27.63M
Net Income Q3 2025 · Mar 31, 2024 −$16.22M